作者
Emir Festic, Vikas Bansal, Ena Gupta, Paul D Scanlon
发表日期
2016/5/3
来源
COPD: Journal of Chronic Obstructive Pulmonary Disease
卷号
13
期号
3
页码范围
312-326
出版商
Taylor & Francis
简介
Background
Inhaled corticosteroids are commonly prescribed for patients with severe COPD. They have been associated with increased risk of pneumonia but not with increased pneumonia-associated or overall mortality.
Methods
To further examine the effects of inhaled corticosteroids on pneumonia incidence, and mortality in COPD patients, we searched for potentially relevant articles in PubMed, Medline, CENTRAL, EMBASE, Scopus, Web of Science and manufacturers' web clinical trial registries from 1994 to February 4, 2014. Additionally, we checked the included and excluded studies' bibliographies. We subsequently performed systematic review and meta-analysis of included randomized controlled trials and observational studies on the topic.
Results
We identified 38 studies: 29 randomized controlled trials and nine observational studies. The estimated unadjusted risk of pneumonia was increased in …
引用总数
2016201720182019202020212022202320243781456633
学术搜索中的文章